Caicun Zhou (Fei Zhou)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Thoracic cancer

Cellular & molecular immunology

Therapeutic advances in medical oncology

BMC cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Weigang Xiu, Jincheng Zheng, Yuwen Zhou, He Du, Jiayu Li, Wei Li, Caicun Zhou, Cai-Cun Zhou, Feng-Ying Wu
A nomogram for the prediction of the survival of patients with advanced non-small cell lung cancer and interstitial lung disease. Cancer medicine (2023)
Caicun Zhou, Haoyue Guo, Xiaolong Zhou, Huikang Xie, Tian Tian, Wencheng Zhao, Guanghui Gao, Anwen Xiong, Lei Wang, Wei Li, Xiaoxia Chen, Yan Zhang, Jue Fan, Fengying Wu, Yongchang Zhang, Caicun Zhou
Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study. Therapeutic advances in medical oncology 14 (2022)
Caicun Zhou, Meng Qiao, Caicun Zhou
The cutting-edge progress of immune-checkpoint blockade in lung cancer. Cellular & molecular immunology 18 (2) (2020)
Xing Li, Lei Wang, Shanhao Chen, Caicun Zhou, Jing Zhao, Wencheng Zhao, Chunxia Su
Adverse impact of bone metastases on clinical outcomes of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Thoracic cancer 11 (10) (2020)
Jie Zhang, Fei Zhou, Huiwei Qi, Huijuan Ni, Qiong Hu, Caicun Zhou, Yunying Li, Irina Baburina, Jodi Courtney, Salvatore J Salamone
Randomized study of individualized pharmacokinetically-guided dosing of paclitaxel compared with body-surface area dosing in Chinese patients with advanced non-small cell lung cancer. British journal of clinical pharmacology 85 (10) (2019)
Caicun Zhou, Wanrong Ma, Wei Li, Huijuan Ni, Guanghui Gao, Xiaoxia Chen, Jie Zhang, Jingyun Shi
Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs. BMC cancer 18 (1) (2018)

Caicun Zhou.css-eqlu8i{font-size:small;padding-left:4px;} (Fei Zhou)

Publication Activity (10 Years)

Top Topics

Top Venues

Caicun Zhou (Fei Zhou)